Pepric

Kapeldreef 60
3001 Leuven
BE
Pepric
Foundation date
14/04/2009
Sector
#Supplier & EngineeringSubsector
Therapeutic areas
- #Cardiovascular
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
- #Skin and subcutaneous tissue
Pepric provides pEPR (particle Electron Paramagnetic Resonance) instruments for in-vitro quantification of superparamagnetic nanoparticles in samples. Fast and accurate measurements by Pepric's robotized particle spectrometer are used for the preclinical tests of hyperthermia or (stem) cell therapies in oncology, cardiology, dermatology, and etc, and in vaccine developments by tracking the pharmacokinetics of therapeutic particles, (stem) cells, medicines or vaccine carriers that utilize super paramagnetic iron oxide nano particles (SPION) or magnetic nano particles (MNP).
Upcoming events
All events-
2206 '23
Translational Research in Crops
Event by: VIB -
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB
Latest news
More news-
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
Read more
-
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Read more
-
Biotalys continues to demonstrate strength of first biocontrol in latest global field trials
Friday June 2nd 2023
Read more